Clinical characteristics | Cases (n = 39a) n (%) | Controls (n = 160a) n (%) | Bivariate analyses | ||
---|---|---|---|---|---|
 |  |  | p-valuee | OR | CI 95% |
HIV transmission by intravenous drug use | Â | Â | 1.00 | 0.88 | 0.28-2.7 |
Yes | 4 (10.2) | 18 (11.5) | Â | Â | Â |
No | 35 (89.8) | 139 (86.6) | Â | Â | Â |
AIDS defining illness before HAART | Â | Â | 0.04b | 2.34 | 1.0-5.3 |
Yes | 11 (28.2) | 23 (14.4) | Â | Â | Â |
No | 28 (71.8) | 137 (85.6) | Â | Â | Â |
AIDS defined by Rio de Janeiro/Caracas criteria | Â | Â | 0.53 | 1.38 | 0.49-3.85 |
Yes | 5 (12.8) | 27 (16.8) | Â | Â | Â |
No | 34 (87.2) | 133 (83.1) | Â | Â | Â |
AIDS defined by CDC adapted criteria | Â | Â | 0.40 | 1.52 | 0.56-4.17 |
Yes | 33 (84.6) | 143 (89.3) | Â | Â | Â |
No | 6 (15.4) | 17 (10.6) | Â | Â | Â |
Comorbidities in the previous year | Â | Â | 0.43 | 0.75 | 0.36-1.54 |
Yes | 24 (61.5) | 109 (68.1) | Â | Â | Â |
No | 15 (38.4) | 51 (31.9) | Â | Â | Â |
Irregular use of HAART in the previous year | Â | Â | 0.07c | 2.22 | 0.9-5.3 |
Yes | 9 (23.1) | 19 (11.9) | Â | Â | Â |
No | 30 (76.4) | 141 (88.1) | Â | Â | Â |
Concomitant medication in the previous year for more than 30 consecutive days | Â | Â | 0.00b | 0.29 | 0.1-0.6 |
Yes | 30 (76.9) | 79 (49.3) | Â | Â | Â |
No | 9 (23.1) | 81 (50.7) | Â | Â | Â |
Year of HIV diagnosis | Â | Â | 0.32 | 1.99 | 0.64-6.11 |
Before 1996 | 5 (12.8) | 11 (6.9) | Â | Â | Â |
After 1996 | 34 (87.2) | 149 (93.1) | Â | Â | Â |
Year of AIDS diagnosis | Â | Â | 0.09c | 8.59 | 0.75-97.3 |
Before 1996 | 2 (5.1) | 1 (0.6) | Â | Â | Â |
After 1996 | 37 (94.8) | 159 (99.4) | Â | Â | Â |
Time from HIV diagnosis until first HAART (months)d | 39.6 ± 52.2 | 12.8 ± 26.9 | 0.57 |  |  |
 | Median: 19.5 (IQR: 1.7-63) | Median: 5.5 (IQR: 2.2-10.7) |  |  |  |
Total time in use of HAART (months)d | 36.1 ± 39,7 | 62.0 ± 32,5 | 0.00b |  |  |
 | Median: 17 (IQR: 13.7-53.5) | Median: 60 (IQR: 33.2-96) |  |  |  |
Time in use of last HAART regimen (months)d | 19.2 ± 18.3 | 44.2 ± 28.6 | 0.00b |  |  |
 | Median: 15 (IQR: 12.2-15.2) | Median: 37 (IQR: 19.2-70.2) |  |  |  |